Skip to main content
. 2017 Nov 20;8(62):106009–106016. doi: 10.18632/oncotarget.22520
b) Stage
Pathologic stage Preoperative stage by magnetic resonance imaging
IA IB II IIIA IIIB IIIC IV
IA 305 (86.2%) 24 (35.8%) 5 (21.7%) 3 (100%) 0 (0%) 24 (34.3%) 5 (41.7%)
IB 22 (6.2%) 30 (44.8%) 4 (17.4%) 0 (0%) 0 (0%) 9 (12.9%) 3 (25.0%)
II 12 (3.4%) 5 (7.5%) 9 (39.1%) 0 (0%) 0 (0%) 3 (4.3%) 1 (8.3%)
IIIA 0 (0%) 3 (4.5%) 3 (13.0%) 0 (0%) 0 (0%) 2 (2.9%) 1 (8.3%)
IIIB 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (1.4%) 0 (0%)
IIIC 12 (3.4%) 5 (7.5%) 1 (4.4%) 0 (0%) 0 (0%) 23 (32.9%) 1 (8.3%)
IV 3 (0.9%) 0 1 (4.4%) 0 (0%) 0 (0%) 8 (11.4%) 1 (8.3%)
Upstaged patients (%) 13.8 19.4 21.7 0 0 11.4 0